Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05787847 · ClinicalTrials.gov registry record · NA
Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT05787847: Completed NA study, sponsored by University of Vermont.
NCT05787847 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05787847, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact stimulant use. Participants in the experimental group will have the opportunity to earn financial incentives for providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, along with health education on the health risks of stimulant use and substance injection. Researchers will compare the experimental group to the control group who will receive health education on the health risks of stimulants use and injection.
Primary Outcome
all samples will be assessed using point-of-care test urine drug test conducted at the center
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Incentives for Abstinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2024-02-14 |
| Est. Completion | 2024-07-30 |
| Phase | NA |
What the finished NCT05787847 record still lists
NCT05787847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Health Education is the first listed.
NCT05787847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05787847 about?
NCT05787847 is a clinical study titled "Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program". The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact...
What is the current status of trial NCT05787847?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2024-02-14. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT05787847?
The interventions under investigation include: Health Education (BEHAVIORAL), Incentives for Abstinence (BEHAVIORAL).
Who is sponsoring clinical trial NCT05787847?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05787847's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI